Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nat Rev Cancer. 2001 Dec;1(3):194-202.

Histone deacetylases and cancer: causes and therapies.

Author information

  • 1Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. paula_marks@mskcc.org

Abstract

Together, histone acetyltransferases and histone deacetylases (HDACs) determine the acetylation status of histones. This acetylation affects the regulation of gene expression, and inhibitors of HDACs have been found to cause growth arrest, differentiation and/or apoptosis of many tumours cells by altering the transcription of a small number of genes. HDAC inhibitors are proving to be an exciting therapeutic approach to cancer, but how do they exert this effect?

PMID:
11902574
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk